Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Photodynamic Therapy Market to grow at a CAGR of 8.22%

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon Aug 08, 2023 8:57am

251 Views

Post# 35577129

RE:RE:Photodynamic Therapy Market to grow at a CAGR of 8.22%

It is the most recent approved therapy for NMIBC. Approved Dec 2022 but not available yet as it is very very difficult to make in large batches. Complex biologic agent. So far it is keytruda and adstiladrin. Keytruda's data is very poor and many wonder how/why it got approved.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario